Bioforward Select Savings

BioForward Member Announcements

Helping you stay connected with BioForward’s member companies and the industry at large

Submit member news stories to news@bioforward.org

Keep up to date on the latest in biotechnology in Wisconsin-including news about fellow members.

  • Platypus Technologies has added two members to its Board of Directors, including Michael Szulczewski of Prairie Technologies, Inc. and Thomas Crabb of Orbital Technologies.  Click here for more information.  Posted August 24, 2009.

  • Prodesse has developed a test capable of identifying the 2009 H1N1 Influenza Virus as Influenza A.  Click here for more information.  Posted August 24, 2009.

  • Centrose has opened a fully functional biological testing facility, part of an expansion that also included hiring more staff members.  Click here for more information.  Posted August 13, 2009.

  • Cellular Dynamics International has appointed two new members to its Scientific Advisory Board.  Click here for more information.  Posted August 12, 2009. 

  • BIO 2010:  Call for Breakout Sessions. If interested in submitting for speaking at the BIO2010 event in Chicago, please click here for more information.  Posted Aug 11, 2009.

  • Potter Lawson has been selected by the Wisconsin Energy Institute to design their building, which will be located on the UW-Madison campus.  Click here for more information.  Posted August 10, 2009.


  • Cambridge Major will dedicate a new manufacturing plant on Thursday that will greatly increase the company’s production capacity.  Click here for more information.  Posted July 29, 2009.


  • Cellular Dynamics International has appointed Junying Yu, a leading stem cell researcher, to a senior research fellowship position.  Click here for more information.  Posted July 22, 2009.

  • Cellular Dynamics International has licensed a patent portfolio regarding the stem cell differentiation selection process.  Read the full press release here.  Posted July 15, 2009.

  • Cellular Dynamics International announced that it has developed a way to generate stem cells from human blood samples.  Read the full press release here.  Posted July 8, 2009.

  • Platypus Technologies, LLC has been awarded a patent for its "Bead-based Assays using a Liquid Crystal Reporter".  Click here to read the full press release.  Posted July 8, 2009.

  • Lucigen, along with their collaborators at Auburn University, has been awarded a grant from the National Science Foundation to develop methods of disease control in farm-raised channel catfish.  Read the full press release here.  Posted July 8, 2009.

  • Cellular Dynamics International and Roche announced that they will expand their existing agreement to test potential for causing damage to heart tissue.  Read the full press release here.  Posted July 2, 2009.

  • GWC Technologies has been awarded a grant from the National Science Foundation for the development of Protein Arrays.  Click here for more information.  Posted July 1, 2009.

  • Gentel Biosciences has launched the APiX Chromogenic Protein Array System for use by the global research community.  For more information, or to read the full press release, click here.  Posted July 1, 2009.

  • Prodesse has announced the licensure of two additional patents, including one covering molecular multiplexing and another covering the molecular detection of prokaryotic organisms.  Read the full press release here.  Posted July 1, 2009.

  • Next Generation Clinical Research has been awarded a small business award from Dane County.  They were also recognized for their community contributions.  Read the full press release here.  Posted June 25th, 2009.

  • Gentel Biosciences announced that it has been invited to join a collaborative Clinical Research and Development consortium aimed at gaining insight into major diseases of pregnancy.  Visit Gentel’s web site for more information.  Posted June 17th, 2009.

  • BioSentinel Pharmaceuticals announced the development of a new real-time testing mechanism for toxins.  Read the full press release here.  Posted June 8th, 2009.

  • National Institutes of Health (NIH) announced two new funding opportunities supported by funds provided by the American Recovery and Reinvesment Act of 2009.  One is geared towards Biomedical Research, Development and Growth and can be found here; the other is a Small Business Catalyst Award for Accelerating Innovative Research and can be found here.  The deadline for applications for both of these awards in September 1.  Posted June 5th, 2009.

  • Cellular Dynamics International (CDI) announced that it has exclusively licensed a key patent portfolio generated by Gordon Keller, PhD, previously from Mount Sinai School of Medicine (MSSM), surround the differentiation of stem cells into human cardiovascual progenitor cells.  More information available at www.cellulardynamics.com. 

  • Prodesse Inc. today announced that Kevin T. Conroy has been elected to the company’s board of directors. More information click here. Posted May 15, 2009.

  • Lucigen announced it has been awarded two new grants to fund additional research and development.The National Science Foundation has awarded Lucigen $100,000 to further develop a nucleic acid replicating enzyme, which was discovered in a sample taken from a boiling-hot spring. The enzyme has several properties that may be useful in cancer diagnosis and infectious disease detection.

    Lucigen will also share in an award of $300,000 from the National Institute of Allergy and Infectious Diseases to develop a simple, point of care test for infectious agents. More information available at www.lucigen.com.  Posted May 14, 2009. 

  • ConjuGon Inc. announces The U.S. Food and Drug Administration (FDA) completed its regulatory review of ConjuGon¹s Investigational New Drug (IND) application for the prevention of Catheter-Associated Urinary Tract Infections (CAUTI).

    This decision clears the way for ConjuGon to begin its proposed Phase Ib clinical trials of C-1205 in indwelling catheterized patients who experience urinary tract infections.ConjuGon plans to begin enrolling patients in the study later this year. More information available at www.conjugon.com.  Posted May 4, 2009.

  • Prodesse announced today that several clinical laboratories using the ProFlu+ Assay have received Centers for Disease Control and Prevention (CDC) confirmation of positive swine flu from specimens initially identified as Influenza A by ProFlu+. More information available at http://www.prodesse.com/usa/news/article72.html  Posted May 4, 2009.

  • Prodesse announced today the results of in silico testing of its ProFlu+ Assay that demonstrate the Assay detects the currently circulating swine flu virus. ProFlu+ detects and differentiates Influenza A, Influenza B and RSV. Prodesse is currently attempting to procure isolates so that reactivity with the swine flu strain can be confirmed. Posted Apr 29, 2009

  • Prodesse announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its ProGastroTM Cd Assay as an in vitro diagnostic product in the United States. The clearance came in less than 90 days from submission. Click here for more information. Posted Apr 17, 2009.

  • Cell Line Genetics LLC received a $250,000 loan from the state. Click here to learn more. Posted Apr 17, 2009.

  • Marquette University recently launched a new graduate certificate in Entrepreneurship. The program will instill entrepreneurial thinking across campus in many disciplines with the aim of providing students the skills needed to launch a business. Learn more here.  Posted Apr 17, 2009.

  • LifeScience Alley (BioForward’s counterpart in MN):  New Technology Showcase 2009 - Call for Applications: Now accepting applications for the 2009 New Technology Showcase now through June 26, 2009. Download the application by clicking here or visitng website at https://www.lifesciencealley.org/programs_events/conferences.aspx#Newtech09.  When completed, submit to Ryan Baird, Communications Manager, LifeScience Alley, at rbaird@lifesciencealley.org or fax to (952) 542-3088. Posted Apr 10, 2009.
     

  • InvivoSciences is the recipient of the gold award for the "World’s Best
    Technology" at the 2009 WBTshowcase, selected by investors, licensees, and tech-commercialization experts based on the company’s Engineered Tissue-based, Real-time, Label-free, High-content and High-throughput Bio detection System for drug development & toxicology testing. More information at www.invivosciences.com.  Posted April 6, 2009.

  • Lucigen announces the that Jeff Williams has joined the company as its new President. Jeff brings over 20 years of relevant experience, having previously held senior level management positions at leading life science and diagnostic companies. More information at www.lucigen.com.  Posted April 2, 2009.

  • Platypus announces the addition of the OrisTM Cell Migration Assembly Kit -FLEX to its product line of cell-based assays.  More information at www.platypustech.com.  Posted March 30, 2009.

  • Centrose announces will now receive additional funding by the National Institute of Allergy and Infectious Disease (NIAID). Centrose, a biopharmaceutical company focused on making drugs better using its CarboConnectTM Platform, received notice today from the NIAID that its anti-fungal drug program will receive $280,000 in grant funding. More information at www.centrosepharma.com.  Posted March 30, 2009.

  • RAPS Wisconsin Chapter announces Regulatory Intelligence:  Staying Current in an Increasily Regulated Global Environment on May 7, 2009 from 5:00 - 8:30pm at GE Heatlhcare Institute in Waukesha, WI.  More information or register at 262-574-8849 or click here.  Posted March 26, 2009.  

  • THRIVE is pleased to announce releasing the first of its annual Sector Snapshots, a review of the strengths of each of Thrive’s target sectors (agriculture, biotechnology and healthcare) in the Madison Region. More information available at www.thrivehere.org/biotechnology.  Posted March 23, 2009.

  • GWC Technologies is pleased to announce development of a new application for high-throughput analysis of small-molecule drug uptake through membranes. For more information visit www.gwctechnologies.com. Posted March 20, 2009.
     

  • Platypus Technologies announces that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $400,000 from the National Institutes of Health. Click here to learn more. Posted March 20, 2009.

  • Mithridion, Inc., a drug development company focusing on serious Central Nervous System disorders including Alzheimer’s disease (AD), announced today that it has been selected to make podium presentations at two major biotechnology venture investment conferences.  The 2nd Annual BIO National Venture Conference is to take place in Boston, MA, March 31-April 1, 2009.  The 11th Annual C21 BioVentures Conference is to take place in Napa CA, Apr 7-9, 2009.  Posted March 13, 2009.

  • Gentel Biosciences announces a technology partnership with Eprogen® to create products for the discovery of new autoantibody biomarkers using whole proteome microarrays. Visit www.gentelbio.com for more information. Posted March 12, 2009.

  • WTN Media is pleased to announce SBA Small Business Journalist of the Year - REGIONAL WINNER - Michael Klein, Founder, President, Editorial Director of WTN Media (Wisconsin Technology Network), Verona - Digitally delivers journalism about small business and the new technology economy. Posted March 12, 2009.

  • GWC Technologies is pleased to announce development of a new application for high-throughput analysis of small-molecule drug uptake through membranes. Developed in collaboration with QBI Life Sciences, the method, published in the March 1 2009 issue of Genetic Engineering News, involves fabrication of membrane arrays on SpotReadyTM chips. Drug absorption is then monitored in real time using the SPRimager®II label-free array reader. Posted March 4, 2009.

  • Platypus Technologies (Madison, WI) announces that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant for $400,000 from the National Institutes of Health. This 2-year funded project will enable the Company to achieve greater sensitivity in detecting nitric oxide (NO) using its patented Liquid Crystal (LC) Technology. Click here for complete details.  Posted March 2, 2009.

  • Quincy Bioscience (Madison, WI) announces that Prevagen® (www.prevagen.com), a dietary supplement made with the jellyfish protein apoaequorin, is now available in select GNC stores across the US. Developed within the University Research Park in Madison, Wisconsin, Prevagen is the breakthrough discovery that can protect brain cells and has been shown to enhance memory. Posted Feb 23, 2009.

  • GWC Technologies Inc is pleased to announce the introduction of dual-channel array imaging for its label-free analysis platform. The dual-channel capability is built on the company’s SPRimager®II array system, which is in use in over a dozen countries for proteomics and bioengineering research. The new system combines an upgraded instrument, the SPRimager®II-D, with a new dual-channel flow cell. Posted Feb 22, 2009.

  • In its 70th anniversary year of practicing exclusively in the area of intellectual property law, Andrus, Sceales, Starke and Sawall, LLP announces that Aaron T. Olejniczak, Peter T. Holsen and Christopher M. Scherer have been named partners in the firm. Posted Feb 2009.

  • Fisher and GE together announce a new partnership. For more details please click here.  Posted Feb 2009.

  • GenTel is planning to launch assays for carbohydrate and protein biomarker profiling this month, and to debut a new high-throughput microarray platform called APiX in June, according to a company official. Posted Feb 2009.

  • Bit 7 (Madison, WI) Rebrands itself as Bjorksten to Better Reflect Wider Scope of Capabilities. For more information log on to www.bjorksten.com. Posted Feb 2009.

     

Medallion Members

  • Platinum
    sponsor-1
  • Silver
    sponsor-3
  • Bronze
    sponsor-4